We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
(+1.5%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.03B |
| 2 |
Valero Energy
VLO
|
+$273M |
| 3 |
Progressive
PGR
|
+$259M |
| 4 |
Advanced Micro Devices
AMD
|
+$256M |
| 5 |
O'Reilly Automotive
ORLY
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$466M |
| 2 |
NVIDIA
NVDA
|
+$435M |
| 3 |
Intel
INTC
|
+$426M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$389M |
| 5 |
Merck
MRK
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.78% |
| 2 | Financials | 11.71% |
| 3 | Healthcare | 11.09% |
| 4 | Consumer Discretionary | 10.64% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
3226
DELISTED
Regulus Therapeutics
RGLS
| $153K | ﹤0.01% |
+85,602
| New | +$199K |
|
|
GTHX
3227
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $153K | ﹤0.01% |
+66,928
| New | +$256K |
|
|
GRSD
3228
Grandstand Limited Ordinary Shares
GRSD
$67M
| $152K | ﹤0.01% |
18,540
| – | – |
|
3229
1stdibs.com
DIBS
$171M
| $152K | ﹤0.01% |
+33,826
| New | +$185K |
|
3230
Kaltura
KLTR
$267M
| $151K | ﹤0.01% |
126,173
| – | – |
|
3231
Taboola.com
TBLA
$1.11B
| $151K | ﹤0.01% |
+43,855
| New | +$177K |
|
3232
Veru
VERU
$37.4M
| $150K | ﹤0.01% |
+17,856
| New | +$207K |
|
3233
Geospace Technologies
GEOS
$75.7M
| $150K | ﹤0.01% |
+16,684
| New | +$188K |
|
3234
Aemetis
AMTX
$121M
| $148K | ﹤0.01% |
+49,234
| New | +$188K |
|
3235
Lifecore Biomedical
LFCR
$190M
| $148K | ﹤0.01% |
+28,837
| New | +$171K |
|
3236
Eve Holding
EVEX
$962M
| $146K | ﹤0.01% |
36,010
| – | – |
|
3237
INmune Bio
INMB
$55.3M
| $146K | ﹤0.01% |
+16,518
| New | +$163K |
|
3238
Ultralife
ULBI
$106M
| $145K | ﹤0.01% |
+13,610
| New | +$145K |
|
3239
Consumer Portfolio Services
CPSS
$206M
| $143K | ﹤0.01% |
14,590
| – | – |
|
3240
Lifetime Brands
LCUT
$210M
| $143K | ﹤0.01% |
+16,644
| New | +$167K |
|
|
ENLC
3241
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $142K | ﹤0.01% |
+10,311
| New | +$138K |
|
3242
LiveOne
LVO
$58.2M
| $141K | ﹤0.01% |
+8,969
| New | +$159K |
|
3243
Sky Harbour Group
SKYH
$386M
| $141K | ﹤0.01% |
+15,222
| New | +$158K |
|
3244
NLI Holdings
NL
$317M
| $140K | ﹤0.01% |
23,157
| – | – |
|
3245
Neuropace
NPCE
$506M
| $139K | ﹤0.01% |
+18,420
| New | +$186K |
|
3246
Caesarstone
CSTE
$79.5M
| $139K | ﹤0.01% |
+27,788
| New | +$157K |
|
3247
Acumen Pharmaceuticals
ABOS
$176M
| $137K | ﹤0.01% |
+56,664
| New | +$180K |
|
3248
Stereotaxis
STXS
$141M
| $135K | ﹤0.01% |
+73,990
| New | +$166K |
|
3249
Priority Technology Holdings
PRTH
$444M
| $133K | ﹤0.01% |
25,156
| – | – |
|
3250
374Water
SCWO
$37.6M
| $132K | ﹤0.01% |
10,975
| – | – |
|
Similar funds
VFT
Nuveen's Q2 2024 Portfolio in Review
As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
- Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
- Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
- Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
- Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
- Nuveen opened 211 new positions and closed 159 in Q2 2024.
- Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.
Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.